Correspondence of Basal Forebrain Resting‐State Functional Connectivity and Cerebral Glucose Metabolism Alterations With Neurotransmitter Maps in Alzheimer's Disease
CNS Neuroscience & Therapeutics · 2026-05 · 32 (5)
DOI: 10.1002/cns.70901 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 09.05.2026. Verfasst von Yujie He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Glucose, Basal Forebrain, Neurotransmitter Agents. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Xuanwu Hospital Talent Convergence Program.
Themen: Demenz
Abstract (Originalsprache)
Aims
To investigate alterations in basal forebrain (BF) subregional functional connectivity (FC), cerebral glucose metabolism, and their spatial correspondence with atlas‐based neurotransmitter distributions in Alzheimer's disease (AD).
Methods
Forty‐two Aβ‐PET‐positive AD patients and forty‐one matched healthy controls (HC) underwent simultaneous PET/MRI. We analyzed resting‐state FC of BF subregions (Ch1‐3, Ch4) and measured cerebral glucose metabolism using 18 F‐FDG PET standardized uptake value ratio (SUVR). Spatial correlations with neurotransmitter maps were assessed using the JuSpace toolbox.
Results
Compared with HC, AD patients showed decreased FC between the left Ch4 and hippocampus/posterior cingulate gyrus, and increased FC between the right Ch4 and precentral/postcentral gyrus. Additionally, AD patients showed increased FC between the left Ch1‐3 and superior temporal gyrus/insula, decreased FC between the right Ch1‐3 and the orbitofrontal gyrus, and increased FC between the right Ch1‐3 and the left temporal lobe (voxel‐level p < 0.001, cluster‐level p < 0.05, GRF correction). These FC changes were spatially correlated with serotonergic (5HT1a, 5HT4, SERT) and dopaminergic (D1, D2, DAT) receptor distributions ( p < 0.05, FDR corrected). Widespread cerebral hypometabolism in temporoparietal and frontal regions was spatially correlated with serotonin, dopamine, GABA, glutamate, and kappa‐opioid systems ( p < 0.05, FDR corrected).
Conclusion
The FC of BF and cerebral metabolic changes in AD show distinct spatial correspondence with specific neurotransmitter systems, highlighting the crucial involvement of serotonin and dopamine in AD pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.
- Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.
ORCID-Profile: Yujie He, Zhigeng Chen, Jie Lu
Förderung
- National Natural Science Foundation of China
- Xuanwu Hospital Talent Convergence Program
Zitieren
APA
He, Y., Xue, H., Bi, S., Wang, Y., Liu, X., Li, Y., Chen, Z., Rong, D., Cui, B., Ma, J., Yan, S., & Lu, J. (2026). Correspondence of Basal Forebrain Resting‐State Functional Connectivity and Cerebral Glucose Metabolism Alterations With Neurotransmitter Maps in Alzheimer's Disease. CNS Neuroscience & Therapeutics, 32(5). https://doi.org/10.1002/cns.70901
Vancouver
He Y, Xue H, Bi S, Wang Y, Liu X, Li Y, et al. Correspondence of Basal Forebrain Resting‐State Functional Connectivity and Cerebral Glucose Metabolism Alterations With Neurotransmitter Maps in Alzheimer's Disease. CNS Neuroscience & Therapeutics. 2026;32(5). doi:10.1002/cns.70901
BibTeX
@article{He2026,
author = {He, Yujie and Xue, Hanxiao and Bi, Sheng and Wang, Yan and Liu, Xiaocao and Li, Yixia and Chen, Zhigeng and Rong, Dongdong and Cui, Bixiao and Ma, Jie and Yan, Shaozhen and Lu, Jie},
title = {Correspondence of Basal Forebrain Resting‐State Functional Connectivity and Cerebral Glucose Metabolism Alterations With Neurotransmitter Maps in Alzheimer's Disease},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {5},
doi = {10.1002/cns.70901}
}
EUVIMED